Companies based in Russian Federation |
|
|
|
|
| Generally we produce desktop applications for Microsoft Windows. More... |
|
|
|
|
| RUSBIZ.COM is a global B2B portal with eMarketplace, eCatalog, Trade Leads listings, Internal Messaging System, Deal Management, Web Store Builder, Discussion Boards, Company Directory and many other advanced features and services. More... |
|
|
|
|
| Quantum Pharmaceuticals develops and markets an original computational drug discovery platform. The core of the computer aided drug design technology is a reliable method to calculate protein-ligand binding affinity. Hit identification module of Quantum molecular modeling technology provides very high hit rate - from 10% to 50% depending on the complexity of the protein target. Quantum technology platform allows also to make reliable Pharmacokinetic and Toxicology predictions at the very early stage based on the molecular structure of compound only.
Quantum Pharmaceuticals has partnerships with leading chemical providers, which enable o work with libraries of several millions of deliverable or synthesizable compounds. Quantum Pharmaceuticals currently have projects in hit/lead identification and optimization with companies and organization around the world, including Top Pharma and Academia.
Quantum Pharmaceuticals is offering drug discovery collaborations on the basis of Quantum Pharmaceuticals’ inhibitors with predicted activity for the variety of therapeutic targets and proper predicted ADMET profile. The contract research services are also available.
The technology platform is applicable virtually in any therapeutic area. It had been already successfully implemented in antibacterial research (FtsZ target), antiviral (HIV-1 integrase), COPD (Human Neutrophil Elastase), oncology (IGFR and other kinases) and many others.
The technology is also applicable in discovery of novel bioactive chemical entities and toxicity research in many others areas, such as crop protection, environmental risk assessment, food supplements, cosmetics etc. More... |
|
|
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10]
next>> |
|